Corbion N.V. (CSU) - Net Assets
Based on the latest financial reports, Corbion N.V. (CSU) has net assets worth €742.60 Million EUR (≈ $868.18 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.42 Billion ≈ $1.66 Billion USD) and total liabilities (€674.30 Million ≈ $788.33 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read CSU current and long-term liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €742.60 Million |
| % of Total Assets | 52.41% |
| Annual Growth Rate | 5.22% |
| 5-Year Change | 34.02% |
| 10-Year Change | N/A |
| Growth Volatility | 8.39 |
Corbion N.V. - Net Assets Trend (2018–2025)
This chart illustrates how Corbion N.V.'s net assets have evolved over time, based on quarterly financial data. Also explore Corbion N.V. (CSU) total assets for the complete picture of this company's asset base.
Annual Net Assets for Corbion N.V. (2018–2025)
The table below shows the annual net assets of Corbion N.V. from 2018 to 2025. For live valuation and market cap data, see Corbion N.V. market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €742.60 Million ≈ $868.18 Million |
-3.87% |
| 2024-12-31 | €772.50 Million ≈ $903.13 Million |
+21.42% |
| 2023-12-31 | €636.20 Million ≈ $743.78 Million |
+1.68% |
| 2022-12-31 | €625.70 Million ≈ $731.51 Million |
+12.92% |
| 2021-12-31 | €554.10 Million ≈ $647.80 Million |
+7.38% |
| 2020-12-31 | €516.00 Million ≈ $603.26 Million |
-2.48% |
| 2019-12-31 | €529.10 Million ≈ $618.57 Million |
+1.71% |
| 2018-12-31 | €520.20 Million ≈ $608.17 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Corbion N.V.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 72.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €706.60 Million | 95.15% |
| Other Components | €36.00 Million | 4.85% |
| Total Equity | €742.60 Million | 100.00% |
Corbion N.V. Competitors by Market Cap
The table below lists competitors of Corbion N.V. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Green Cross Corp
KO:006280
|
$1.06 Billion |
|
Elsight Ltd
AU:ELS
|
$1.06 Billion |
|
Anhui Xinlong Electrical Co Ltd
SHE:002298
|
$1.06 Billion |
|
BioPharma Credit PLC
LSE:BPCR
|
$1.06 Billion |
|
Anhui Expressway Company Limited
F:HU7
|
$1.06 Billion |
|
Bank Artos Indonesia Tbk PT
JK:ARTO
|
$1.06 Billion |
|
Baota Industry Co Ltd
SHE:000595
|
$1.06 Billion |
|
Guangxi Guidong Eletric Power Co Ltd
SHG:600310
|
$1.06 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Corbion N.V.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 772,500,000 to 742,600,000, a change of -29,900,000 (-3.9%).
- Net income of 74,800,000 contributed positively to equity growth.
- Dividend payments of 37,200,000 reduced retained earnings.
- Share repurchases of 10,000,000 reduced equity.
- Other factors decreased equity by 57,500,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €74.80 Million | +10.07% |
| Dividends Paid | €37.20 Million | -5.01% |
| Share Repurchases | €10.00 Million | -1.35% |
| Other Changes | €-57.50 Million | -7.74% |
| Total Change | €- | -3.87% |
Book Value vs Market Value Analysis
This analysis compares Corbion N.V.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.39x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.02x to 1.39x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €8.85 | €17.90 | x |
| 2019-12-31 | €9.00 | €17.90 | x |
| 2020-12-31 | €8.76 | €17.90 | x |
| 2021-12-31 | €9.40 | €17.90 | x |
| 2022-12-31 | €10.60 | €17.90 | x |
| 2023-12-31 | €10.77 | €17.90 | x |
| 2024-12-31 | €13.30 | €17.90 | x |
| 2025-12-31 | €12.90 | €17.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Corbion N.V. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.07%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.90%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 1.91x
- Recent ROE (10.07%) is below the historical average (13.05%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 10.44% | 6.05% | 0.93x | 1.86x | €2.28 Million |
| 2019 | 4.88% | 2.64% | 0.89x | 2.06x | €-27.11 Million |
| 2020 | 14.17% | 7.41% | 0.92x | 2.08x | €21.50 Million |
| 2021 | 14.13% | 7.31% | 0.80x | 2.42x | €22.89 Million |
| 2022 | 14.38% | 6.17% | 0.85x | 2.73x | €27.43 Million |
| 2023 | 11.46% | 5.77% | 0.75x | 2.65x | €9.28 Million |
| 2024 | 24.88% | 14.92% | 0.83x | 2.00x | €114.95 Million |
| 2025 | 10.07% | 5.90% | 0.89x | 1.91x | €540.00K |
Industry Comparison
This section compares Corbion N.V.'s net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $3,039,854,957
- Average return on equity (ROE) among peers: -28.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Corbion N.V. (CSU) | €742.60 Million | 10.44% | 0.91x | $1.06 Billion |
| GRAPHENE MANUFACT.GROUP (0GF) | $8.54 Million | -86.66% | 0.78x | $152.93 Million |
| Orion Engineered Carbons SA (0OE) | $474.90 Million | 9.31% | 2.91x | $318.41 Million |
| H&R GmbH & Co. KGaA (2HRA) | $471.16 Million | 9.06% | 1.04x | $183.88 Million |
| Dotz Nano Ltd (57N) | $421.99K | -248.22% | 1.80x | $3.81 Million |
| EXPLOS. PROD. CHIM.EO 31 (9Z50) | $144.93 Million | 14.73% | 2.07x | $536.15 Million |
| Altech Chemicals Ltd (A3Y) | $88.93 Million | 2.62% | 0.01x | $27.76 Million |
| AlzChem Group AG (ACT) | $68.66 Million | 28.68% | 4.16x | $1.83 Billion |
| AIR LIQUIDE ADR 1/5/EO 11 (AILA) | $24.57 Billion | 11.23% | 1.02x | $103.86 Billion |
| AKZO NOBEL SPONS.ADRS 1/3 (AKUP) | $4.55 Billion | 9.72% | 2.20x | $8.57 Billion |
| BRAIN Biotech AG (BNN) | $23.01 Million | -35.97% | 2.08x | $51.56 Million |
About Corbion N.V.
Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation… Read more